Usana Health Sciences Inc(USNA) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Oct 28 at 4:01 PM ET (Korea 10/29 05:01)
Full metrics table
| Index | RUT | P/E | - | EPS (ttm) | -1.2 | Insider Own | 40.9% | Shs Outstand | 18.5M | Perf Week | 2.81% |
| Market Cap | 0.27B | Forward P/E | 8.26 | EPS next Y | 132.89% | Insider Trans | -0.43% | Shs Float | 10.9M | Perf Month | -0.54% |
| Enterprise Value | 0.15B | PEG | - | EPS next Q | 0.11 | Inst Own | 61.55% | Short Float | 7.13% | Perf Quarter | -34.06% |
| Income | -0.02B | P/S | 0.3 | EPS this Y | -60.62% | Inst Trans | 14.26% | Short Ratio | 3.78 | Perf Half Y | -21.9% |
| Sales | 0.91B | P/B | 0.51 | EPS next 5Y | - | ROA | -3.08% | Short Interest | 0.78M | Perf YTD | -25.52% |
| Book/sh | 28.51 | P/C | 1.6 | EPS past 3/5Y | -45.56% -37.06% | ROE | -4.19% | 52W High | -38.02% ($23.59) | Perf Year | -28.09% |
| Cash/sh | 9.12 | P/FCF | 16.96 | Sales past 3/5Y | -2.51% -4% | ROIC | -4.21% | 52W Low | 16.31% ($12.57) | Perf 3Y | -67.45% |
| Dividend Est. | - | EV/EBITDA | 1.82 | EPS Y/Y TTM | -166.61% | Gross Margin | 73.9% | Volatility(W/M) | 3.93% 4.02% | Perf 5Y | -84.56% |
| Dividend TTM | - | EV/Sales | 0.16 | Sales Y/Y TTM | 1.57% | Oper. Margin | 4.54% | ATR (14) | 0.62 | Perf 10Y | -77.31% |
| Dividend Ex-Date | - | Quick Ratio | 1.84 | EPS Q/Q | -322.06% | Profit Margin | -2.43% | RSI (14) | 49.1 | Recom | 3 |
| Dividend Gr. 3/5Y | - | Current Ratio | 2.66 | Sales Q/Q | -5.33% | SMA20 | -0.71% ($14.72) | Beta | 0.66 | Target Price | $25 |
| Payout | - | Debt/Eq | 0 | Earnings | 2026/11/3 | SMA50 | 0.77% ($14.51) | Rel Volume | 0.97 | Prev Close | $14.07 |
| Employees | 1570 | LT Debt/Eq | 0 | EPS/Sales Surpr. | -116.28% -4.99% | SMA200 | -19.52% ($18.17) | Avg Volume(3M) | 0.21M | Price | $14.62 |
| IPO | 1996/5/30 | Option/Short | Yes/Yes | Trades | 2254 | Volume | 199,459 | Change | 3.91% |
🌿 A global health functional food company that supplies science-based nutritional supplements through direct selling (network marketing). Headquartered in the US, it operates in around 20 countries, with vertical integration via its own manufacturing facilities and an extensive independent distributor network serving as its core competitive strengths.
Over the past 1 year, on the lower side
38% below its 1-year high.
Traded about as much as usual. That is 97% of its average volume.
Next earnings report: November 3
6 days to go.
USNA keeps an operating profit but posts a net loss
Of every $100 in sales, $4.54 is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by -60.6% this year.
Tap to view numbers
Relative to sales, the price is about the industry average
Loss-making, so we compare on sales. For a company selling $100 a year, you would pay $30. Peers typically go for $43. Compared with its own 5-year average, it is 195% pricier now.
Tap to view numbers
Results came in about as expected
Slight tendency to beat estimates
Tap to view numbers
The outlook is positive
Analyst sentiment is Hold.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -84.6%. The S&P 500 did +69% over the same period.
Tap to view numbers
No dividend
There is no profit to distribute yet.
Ownership looks stable
Institutions hold 61.5%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #37 of 61 in the industry
Based on market cap of $270M.
PRE#34 Prenetics Global Limited $314M PER - 
BRCC#35 BRC Inc $304M PER - 
OTLY#36 Oatly Group AB ADR $273M PER - USNA#37 Usana Health Sciences Inc $270M PER - 
NATR#38 Nature's Sunshine Products Inc $219M PER 12.4 
FAQ
What kind of company is USNA?
USNA belongs to the Consumer Defensive sector and operates in the Packaged Foods industry.
What is the market cap of USNA?
The market cap of USNA is approximately $270M, ranking 3,765 within its sector.
What is the 52-week high and low for USNA?
USNA has recorded a 52-week high of $23.59 and a low of $12.57.
